WHO provides 2 conditional recommendations for casirivimab-imdevimab combination therapy in COVID-19.

Dunne, Cody; Lang, Eddy

Dunne, Cody; Lang, Eddy.

Dunne C; Department of Emergency Medicine, University of Calgary, Calgary, Alberta, Canada (C.D., E.L.).
Lang E; Department of Emergency Medicine, University of Calgary, Calgary, Alberta, Canada (C.D., E.L.).

Ann Intern Med ; 175(1): JC6, 2022 01.

Article in English | MEDLINE | ID: covidwho-1631869

ABSTRACT

ABSTRACT

SOURCE CITATION Rochwerg B, Agarwal A, Siemieniuk RA, et al. Update to living WHO guideline on drugs for covid-19. BMJ. 2021;374n2219. 34556469.

Subject(s)

COVID-19; Antibodies, Monoclonal, Humanized; Humans; SARS-CoV-2; World Health Organization

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: Ann Intern Med Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google